Barinthus Biotherapeutics (BRNS) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$3.5 million.
- Barinthus Biotherapeutics' Other Gross PP&E Adjustments rose 5954.29% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.5 million, marking a year-over-year increase of 5954.29%. This contributed to the annual value of $10.6 million for FY2024, which is 5074.52% up from last year.
- Barinthus Biotherapeutics' Other Gross PP&E Adjustments amounted to -$3.5 million in Q3 2025, which was up 5954.29% from -$4.3 million recorded in Q2 2025.
- In the past 5 years, Barinthus Biotherapeutics' Other Gross PP&E Adjustments registered a high of $10.6 million during Q4 2024, and its lowest value of -$10.0 million during Q2 2022.
- For the 5-year period, Barinthus Biotherapeutics' Other Gross PP&E Adjustments averaged around -$4.9 million, with its median value being -$7.8 million (2024).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 25733.14% in 2022, then surged by 217258.06% in 2023.
- Quarter analysis of 5 years shows Barinthus Biotherapeutics' Other Gross PP&E Adjustments stood at -$6.9 million in 2021, then surged by 104.51% to $310000.0 in 2022, then skyrocketed by 2172.58% to $7.0 million in 2023, then skyrocketed by 50.75% to $10.6 million in 2024, then crashed by 133.33% to -$3.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$3.5 million in Q3 2025, compared to -$4.3 million in Q2 2025 and -$4.3 million in Q1 2025.